Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05286931
NA

SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection

Sponsor: University of Washington

View on ClinicalTrials.gov

Summary

This study aims to test the effectiveness of using of SpeeDx Resistance Plus assay to guide treatment of Neisseria gonorrhoeae (Ng) in a sexual health clinic setting.

Official title: Evaluation of SpeeDx's Ciprofloxacin gyrA Assay for Clinical Care of STD Clinic Patients With Neisseria Gonorrhea

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1800

Start Date

2022-03-03

Completion Date

2026-12-31

Last Updated

2022-03-18

Healthy Volunteers

Yes

Interventions

DRUG

Ciprofloxacin 500 mg

Ciprofloxacin 500 MG, taken once orally.

Locations (1)

Public Health -- Seattle & King County Sexual Health Clinic

Seattle, Washington, United States